Lung Tissue Research Consortium

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

247 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-02-23

Study Completion Date

2019-02-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The LTRC will facilitate histopathological research of pulmonary diseases by collecting lung tissues from donors and preparing and distributing collections of tissue specimens to researchers within and outside the LTRC. Collections of specimens will be linked to individual clinical data appropriate to the particular disease. The primary goal of the LTRC is to identify participants with suspected lung cancer or metastatic disease who are willing to provide informed consent for research use of their specimens and data. Secondarily, the LTRC investigators intend to collect clinical data, limited exposure data, physiologic studies, and radiographic studies from these participants.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Collection of Lung Fluid and Tissue Samples for Research

NCT00471250

Leukocyte Disorders Respiratory Tract Diseases Bronchoscopy

RECRUITING

Definition of the Status of the Human Lung Stem Cell Niches ex Vivo in Tissue Biopsies Performed in Patients With Emphysema and Interstitial Fibrosis

NCT02705144

Lung Diseases, Interstitial

UNKNOWN

Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies

NCT01776398

Chronic Obstructive Pulmonary Disease (COPD) Smoking Smoking Cessation +3 more

RECRUITING

Analyzing Lung Tissue in People With and Without Chronic Obstructive Pulmonary Disease Who Are Undergoing Lung Transplantation

NCT00756522

Pulmonary Disease, Chronic Obstructive

COMPLETED

Telomeres Length in Israeli Fibrotic ILD Patients

NCT06885515

Pulmonary Fibrosis

NOT_YET_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Obstructive Pulmonary Disease Interstitial Lung Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Lung biopsy/lobectomy

Adults ages 21 or older who are undergoing lung surgery for suspected malignancy or metastases.

Lung biopsy/lobectomy

Intervention Type PROCEDURE

Lung biopsies and lobectomies are not experimental. Participants will undergo a lung biopsy or a lobectomy as part of standard of care.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lung biopsy/lobectomy

Lung biopsies and lobectomies are not experimental. Participants will undergo a lung biopsy or a lobectomy as part of standard of care.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults ages 21 or older who are undergoing lung surgery for suspected malignancy or metastases.

Exclusion Criteria

* Diagnosis of cystic fibrosis or pulmonary hypertension.
* Any other condition that, in the judgment of the investigator, precludes participation.
* Failure to obtain written consent.

Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes